Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian stock market continues to slide
Thu, 21 Nov 01:30 pm

Backed by persistent selling activity across index heavyweights, Indian markets continued to trade weak during the post noon trading session. All the sectoral indices are trading in the red with banking and capital goods witnessing maximum selling pressure.

BSE-Sensex is down by 324 points and NSE-Nifty is trading down by 99 points. While BSE Mid Cap is trading down by 0.6%, BSE Small Cap index is trading down by 0.69%. The rupee is trading at 62.88 to the US dollar.

Majority of the power stocks are trading in the red with Indiabulls Power and GVK Power being the biggest losers. As per a leading financial daily, the Maharashtra government has approved the tariff revision recommended by the Deepak Parekh panel for power supplied from Tata Power's 4,000 MW ultra mega power project (UMPP) in Mundra but with a few conditions. MahaVitaran, the power distribution arm of Maharashtra, has tied up for 800 MW from Mundra UMPP but is currently getting only 80% of it. Among the conditions laid down is that the tariff should be reduced in line with fall in price of imported coal as also an undertaking by the firm to reduce its return on equity (ROE) as far as possible. The tariff after revision will increase by 59 paise per unit for MahaVitaran. The Central Electricity Regulatory Commission (CERC) had earlier allowed Tata Power's Mundra project ,that supplies power to five states, to pass on high cost of imported coal to consumers through tariff-hikes. The regulator had also asked states that receive power from the project to file affidavit in this regard. Reportedly, Punjab and Haryana states have opposed CERC's approval and moved the court against the decision. Tata Power stock is currently trading down by 0.5%.

Most of the MNC pharma stocks are trading in the red with Pfizer India and GSK Pharma being the major losers. Pfizer India recently declared that it will holding a board meeting where it will be considering an amalgamation with Wyeth India. It must be noted that in 2009, the parent company Pfizer Inc. had acquired Wyeth Ltd. Since some time, Pfizer India had been providing various services to Wyeth Ltd's Indian arm, however both the companies continued to function as two separate entities in India. The board meeting is scheduled for 23rd Nov 2013, when both the managements will meet and various merger related issues will be decided upon.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian stock market continues to slide". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.